Comment submitted by Beveridge & Diamond

Summary: Beveridge & Diamond, representing pharmaceutical industry clients, opposes the inclusion of "pharmaceuticals" as a broad, undifferentiated contaminant group in the Drinking Water Contaminant Candidate List (CCL 6). They argue that the current definition is overly broad, risks causing public alarm over safe medicines, and request that the EPA instead focus on specific active pharmaceutical ingredients (APIs) using a science-based prioritization process.